The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021

Wallace, Megan; R. Woodworth, Kate; W. Gargano, Julia; M. Scobie, Heather; Blain, Amy; Moulia, Danielle; E. Chamberland, Mary; Reisman, Nicole; C. Hadler, Stephen; R. MacNeil, Jessica; Campos‐Outcalt, Doug; L. Morgan, Rebecca; F. Daley, Matthew; R. Romero, José; Keipp Talbot, H.; M. Lee, Grace; P. Bell, Beth; E. Oliver, Sara

doi:10.15585/mmwr.mm7020e1

Public

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021

Published in MMWR Morbidity and Mortality Weekly Report • May 14, 2021

Authors:

Megan Wallace

Kate R. Woodworth

Julia W. Gargano

Abstract

In May 2021, after a systematic review of all available data,â¯the Advisory Committee on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTechâ¯COVID-19 vaccine in adolescents aged 12â15 years for the prevention of COVID-19.

Subject

Interim

Advisory committee

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!